HIMSS TV is your Insider’s Guide to everything HIMSS. We are the world’s first online broadcasting network, focused on global innovation and how information and technology are driving change in healthcare.
  Home
Detecting neurodegenerative diseases before symptoms appear
Population Health

Detecting neurodegenerative diseases before symptoms appear

6:03

Russ Lebovitz, CEO of Amprion, discusses the company’s partnership with Mayo Clinic Laboratories to expand access to its test that detects misfolded proteins associated with Parkinson’s, Lewy body dementia, and multiple system atrophy.

Read More
Read Less

Population Health - Similar Videos View more in Population Health

4:30

How technology can improve outcomes for the chronically ill

Dan Shields, CEO of digital medicine at Ochsner Health, discusses the health system's 10-year project that leverages proven digital tools to help patients with conditions such as hypertension and diabetes better manage their care.

How technology can improve outcomes for the chronically ill
Dan Shields, CEO of digital medicine at Ochsner Health, discusses the health system's 10-year project that leverages proven digital tools to help patients with conditions such as hypertension and diabetes better manage their care.
4:30
4:14

How states track immunization histories to guide care decisions

Rebecca Coyle, executive director of the American Immunization Registry Association, talks about immunization registries consolidating vaccine records from multiple providers and recommending additional needed doses.

How states track immunization histories to guide care decisions
Rebecca Coyle, executive director of the American Immunization Registry Association, talks about immunization registries consolidating vaccine records from multiple providers and recommending additional needed doses.
4:14
3:27

A direct-to-consumer test for preeclampsia

Aimee Corso, senior vice president of growth at Mirvie, discusses the company's pregnancy-focused women's health company and its new offering, a direct-to-consumer test to predict preeclampsia before it occurs using RNA analysis.

A direct-to-consumer test for preeclampsia
Aimee Corso, senior vice president of growth at Mirvie, discusses the company's pregnancy-focused women's health company and its new offering, a direct-to-consumer test to predict preeclampsia before it occurs using RNA analysis.
3:27